HMGA1 and breast cancer: In addition, Sgubin et al. [22] also found that HMGA1 plays an important role in tumor drug resistance, and after silencing HMGA1, the sensitivity of BC cells to “paclitaxel” (paclitaxel is a drug used for TNBC treatment) increased.